Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001070081-25-000019
Filing Date
2025-05-06
Accepted
2025-05-06 16:34:25
Documents
91
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20250331x10q.htm   iXBRL 10-Q 2039436
2 EX-31.1 tmb-20250331xex31d1.htm EX-31.1 10821
3 EX-31.2 tmb-20250331xex31d2.htm EX-31.2 10632
4 EX-32.1 tmb-20250331xex32d1.htm EX-32.1 5838
5 EX-32.2 tmb-20250331xex32d2.htm EX-32.2 6033
  Complete submission text file 0001070081-25-000019.txt   11430996

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20250331.xsd EX-101.SCH 80651
7 EX-101.CAL tmb-20250331_cal.xml EX-101.CAL 84588
8 EX-101.DEF tmb-20250331_def.xml EX-101.DEF 348905
9 EX-101.LAB tmb-20250331_lab.xml EX-101.LAB 735363
10 EX-101.PRE tmb-20250331_pre.xml EX-101.PRE 545794
94 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20250331x10q_htm.xml XML 2273290
Mailing Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059
Business Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35969 | Film No.: 25917825
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)